References
- Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29. 10.1002/(sici)1097-0215(19990924)83:1<;18::aid-ijc5>3.0.co;2-m
- Li J, Xu W, Liu F, Huang S, He M. GSTM1 polymorphism contribute to colorectal cancer in Asian populations: a prospective meta-analysis. Sci Rep 2015; 29: 12514. doi: 10.1038/srep12514
- Han JH, Lee HJ, Choi HJ, Yun KE, Kang MH. Lymphocyte DNA damage and plasma antioxidant status in Korean subclinical hypertensive patients by glutathione S-transferase polymorphism. Nutr Re Pract 2017; 11: 214-22. doi: 10.4162/nrp.2017.11.3.214
- Bellacosa A, Staal S, Tsichlis P. A retroviral oncogene, Akt, encoding a serinethreonine kinase containing an SH2-like region. Science 1991; 254: 274-77. doi: 10.1126/science.254.5029.274
- Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, McCubrey JA. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cell biology. Cancers 2010; 2: 1576-96. doi: 10.3390/cancers2031576
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74. doi: 10.1016/j.cell.2011.02.013
- Zhi-Ze C. Berberine induced apoptosis of human osteosarcoma cells by inhibiting phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signal pathway activation. Iran J Public Health 2016; 45: 578-85. PMID: 27398330
- Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell 2017; 169: 381-405. doi: 10.1016/j.cell.2017.04.001
- Wang L-q, He Y, Wan H-f, Zhou H-f, Yang J-h, Wan H-t. Protective mechanisms of hypaconitine and glycyrrhetinic acid compatibility in oxygen and glucose deprivation injury. J Zhejiang Univ Sci B 2017; 18: 586-96. doi: 10.1631/jzus.B1600270
- Minsu P, Choi HK, An JH. Taurine Activates BMP-2/Wnt3a-Mediated Osteoblast Differentiation and Mineralization via Akt and MAPK Signaling. Iran J Public Health 2019; 48: 1960-70. PMID: 31970094
- Kumar A, Rajendran V, Sethumadhavan R, Purohit R. AKT kinase pathway: a leading target in cancer research. Sci World J 2013; 2013: 1-6. doi: 10.1155/2013/756134
- Malstrom S, Tili E, Kappes D, Ceci JD, Tsichlis PN. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. PNAS 2001; 98: 14967-72. doi: 10.1073/pnas.231467698
- Mende I, Malstrom S, Tsichlis PN, Vogt PK, Aoki M. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 2001; 20: 4419-23. doi: 10.1038/sj.onc.1204486
- Ocana A, Vera-Badillo F, Al-Mubarak M, Templeton AJ., Corrales-Sanchez V, Diez-Gonzalez, et al. Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis. PLoS One 2014; 9: e95219. doi: 10.1371/journal.pone.0095219
- Xu J, Wang Z, Hu L, Yin Z, Huang M, Hu Z, et al. Genetic variants in the PI3K/ PTEN/Akt/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. Asian Pacific J Cancer Prev 2012; 13: 2157-62. doi: 10.7314/apjcp.2012
- Bizhani F, Hashemi M, Danesh H, Nouralizadeh A, Narouie B, Bahari G, et al. Association between single nucleotide polymorphisms in the PI3K/AKT/ mTOR pathway and bladder cancer risk in a sample of Iranian population. EXCLI J 2018; 2: 3-13. doi: 10.17179/excli2017-329
- Imran M, Park TJ, Lim IK. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid. Eur J Cancer 2012; 48: 2474-85. doi: 10.1016/j.ejca.2012.01.028
- Imran M, Lim IK. Regulation of BTG2/TIS21/PC3 expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions. Cell Signal 2013; 25: 2400-12. doi: 10.1016/j.cellsig.2013.07.015.
- Imran M, Park JS, Lim IK. Stress-induced NF-κB activation differentiates promyelocytic leukemia cells to macrophages in response to all-trans-retinoic acid. Cell Signal 2015; 27: 694-706. doi: 10.1016/j.cellsig.2014.11.019
- Zubair H, Lim IK, Safi SZ, Rehman F, Imran M. Akt downregulates B-cell translocation gene-2 expression via Erk1/2 inhibition for proliferation of cancer cells. Ann Clin Lab Sci 2020; 50: 711-16. PMID: 33334784
- Gul S, Khisroon M, Khan A, Gul S, Khan G N. Assessment of genotoxicity in lymphocytes of active and passive cigarette smokers attenuated with green tea. Pak J Zool 2019; 51: 1131-36. doi: 10.17582/journal.pjz/2019.51.3.1131.1136
- Singh NP, McCoy MT, Tice R.R, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-91. doi: 10.1016/0014-4827(88)90265-0
- Zhang Z, Chen Q, Zhang J, Wang Y, Hu X, Yin S, et al. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: a meta-analysis in Asian population. Sci Rep 2017; 7: 1-11. doi: 10.1038/s41598-017-17250-z
- Schwingshackl L, Schwedhelm C, Hoffmann G, Knuppel S, Preterre AL, Iqbal K, et al. Food groups and risk of colorectal cancer. Int. J. Cancer 2018; 142: 1748-58. doi: 10.1002/ijc.31198
- Xu W, Ni Z, Zhang M, Chen J, Zhang L, Wu S, et al. The role of polymorphisms in genes of PI3K/Akt signaling pathway on prostate. J Cancer 2019; 10: 102331. doi: 10.7150/jca.26472
- Nishizawa D, Kasai S, Hasegawa J, Sato N, Tanioka F, Sugimura H, et al. Association between AKT1 gene polymorphism rs2498794 and smoking-related traits with reference to cancer susceptibility. Biomed Res Int 2015; 2015: 316829. doi: 10.1155/2015/316829
- Avan A, Avan A, Large TYSL, Mambrini A, Funel N, Maftouh M, et al. AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. PLoS One 2014; 9: e108057. doi: 10.1371/journal.pone.0108057
- Li Y, Zhu L, Yao H, Zhang Y, Kong X, Chen L, et al. Association of inflammation-related gene polymorphisms with susceptibility and radiotherapy sensitivity in head and neck squamous cell carcinoma patients in northeast China. Front Oncol 2021; 11: 651632. doi: 10.3389/fonc.2021.651632
- Giovannetti E, Zucali PA, Peters GJ, Cortesi F, D’Incecco A, Smit EF, et al. Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non–small cell lung cancer patients treated with gefitinib. Mol Cancer Ther 2010 9: 581-93. doi: 10.1158/1535-7163
- Blest-Hopley G, Colizzi M, Prata D. Giampietro V, Brammer M, McGuire P, et al. Epigenetic mediation of AKT1 rs1130233’s effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing. Brain Sci 2021; 11: 1240, doi: 10.3390/brainsci11091240
- Piao Y, Li Y, Xu Q, Liu J-w, Xing C-z, Xie X-d, et al. Association of MTOR and AKT gene polymorphisms with susceptibility and survival of gastric cancer. PLOS ONE 2015; 10: e0136447. doi: 10.1371/journal.pone.0136447
- Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R, et al. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Investig 2008; 118: 2200-08. doi: 10.1172/JCI34725
- Piscitello D, Varshney D, Lilla S, Vizioli MG, Reid C, Gorbunova V, et al AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11. Oncogene 2018; 37: 427-38. doi: 10.1038/onc.2017.340
- Gol MT, Rodemann, HP, Dittmann K. Depletion of Akt1 and Akt2 impairs the repair of radiation-induced DNA double strand breaks via homologous recombination. Int J Mol Sci 2019; 20: 6316. doi: 10.3390/ijms20246316
- Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal 2011; 23:1515-27. doi: 10.1016/j.cellsig.2011.05.004
- Cortes U, Moyret-Lalle C, Falette N, Guillot C, Rimokh R, Wang Q, et al. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog 2000; 27: 57-64. doi: 10.1038/ng1296-482